Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Binge-watching TV threatens heart health

A study on the effect of different sedentary behaviors on CV health has pinned binge-watching television as a more harmful activity than sitting at a desk job, though the negative effects of both can potentially be reversed with exercise.

Thumbnail

SAVR strips the average patient of nearly 2 years of life

Patients with aortic stenosis who undergo SAVR live on average 1.9 years less than the general population, according to a study published in the July issue of the Journal of the American College of Cardiology.

Thumbnail

‘The next target after vaccines’: Fighting fake news about statins

Fear-based “fake news” about statin therapy is driving non-adherence to the drugs in the U.S., according to an editorial published in JAMA Cardiology June 26, fostering a culture of mistrust and misinformation that could easily deter heart patients from a treatment that might be beneficial to them.

Thumbnail

Apple-shaped women face greater risk of CVD than pear-shaped women

Body fat distribution could be a key predictor of heart disease risk in postmenopausal women, according to a July 1 study that found “apple”-shaped women are more prone to CVD than their “pear”-shaped counterparts.

Thumbnail

CV stents market expected to exceed $13B by 2025

The cardiovascular stents market is expected to reach $13.1 billion by 2025, up from $7.8 billion in 2017, according to projections from Fortune Business Insights.

UTIs linked to 5 times the risk of ischemic stroke

Infections—most notably urinary tract infections—were linked to a significantly increased risk of acute ischemic stroke in a recent study out of the Icahn School of Medicine at Mount Sinai.

FDA fast-tracks empagliflozin for treatment of chronic HF

The FDA on June 26 granted Boehringer Ingelheim and Eli Lilly and Company’s drug empagliflozin Fast Track designation for the treatment of chronic heart failure, the companies announced.

Thumbnail

Under Armour files patent application for BP-monitoring sneakers

Sportswear brand Under Armour filed a patent application this week for a new “smart” shoe that’s able to take a wearer’s blood pressure and help them recover faster from a workout.